Skip to main content
. 2020 May 27;73(3):450–459. doi: 10.1093/cid/ciaa646

Table 4.

ELF Index, FIB4, and APRI Performance in All Patients

Variable ELF Index FIB4 APRI ELF ~ FIB4 ELF ~ APRI FIB4 ~ APRI
n = 206 n = 206 n = 206 P P P
Any/mild fibrosis ≥F1 AUC 0.85 0.73 0.74
SEa 0.027 0.041 0.042 .010 .030 .695
95% CIb .80–.90 .67–.79 .68–.80
Moderate fibrosis ≥F2 AUC 0.91 0.77 0.75 .0001 .0001 .399
SEa 0.025 0.0337 0.0349
95% CIb .86–.94 .71–.83 .69–.81
Advanced fibrosis ≥F3 AUC 0.976 0.77 0.73 .0001 .0001 .054
SEa 0.010 0.037 0.041
95% CIb .95–.99 .71–.83 .66–.79
Cirrhosis F4 AUC 0.98 087 084 .003 .001 .146
SEa 0.012 0.044 0.050
95% CIb .95–.99 .82–.91 .78–.89

Abbreviations: APRI, aspartate to platelet ratio index; AUC, area under the curve; CI, confidence interval; ELF, enhanced liver fibrosis; SE, standard error.

aDeLong et al 1988.

bBinomial exact.